Shiqing Chen

3D Medicines, Inc.

Shanghai

China

SCHOLARLY PAPERS

1

DOWNLOADS

112

TOTAL CITATIONS

1

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Immunotherapy Efficacy and Safety of Programmed Cell Death 1 (PD-1) versus Programmed Death Ligand-1 (PD-L1) Inhibitors in Pan-Cancer Patients: A Systematic Review and Meta-Analysis

Number of pages: 36 Posted: 12 May 2019
Jianchun Duan, Longgang Cui, Xiaochen Zhao, Hua Bai, Guoqiang Wang, Zhengyi Zhao, Jing Zhao, Shiqing Chen, Jia Song, Chuang Qi, Qing Wang, Mengli Huang, Yuzi Zhang, Depei Huang, Yuezong Bai, Feng Sun, Shangli Cai, Zhijie Wang and Jie Wang
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology, 3D Medicines, Inc., 3D Medicines, Inc., Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology, 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., 3D Medicines, Inc., Peking University - Department of Epidemiology and Biostatistics, 3D Medicines, Inc., Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Molecular Oncology and Chinese Academy of Medical Sciences & Peking Union Medical College - State Key Laboratory of Molecular Oncology
Downloads 112 (534,287)
Citation 1

Abstract:

Loading...